MM402 (R(-)-MDMA) — Initial data
2026
DT402 Initial Data in ASD | 2026Source filing
DEFINIUM THERAPEUTICS INC · Data as of 2026-09-08
2026
DT402 Initial Data in ASD | 2026Source filing
Q3 2026
Topline data expected in early 3Q 2026.Source filing
H2 2026
Topline data from the 12-week double-blinded period (Part A) is anticipated in the second half of 2026.Source filing
H2 2026
Topline data from the 12-week double-blind period (Part A) is anticipated in the second half of 2026.Source filing
2027
Topline data expected in 2027.Source filing